Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 67


LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.

Pan JH, Zhou H, Cooper L, Huang JL, Zhu SB, Zhao XX, Ding H, Pan YL, Rong L.

Front Immunol. 2019 Jan 29;10:6. doi: 10.3389/fimmu.2019.00006. eCollection 2019.


A Mechanism Underlying Attenuation of Recombinant Influenza A Viruses Carrying Reporter Genes.

Zhao X, Wang L, Cui Q, Li P, Wang Y, Zhang Y, Yang Y, Rong L, Du R.

Viruses. 2018 Nov 30;10(12). pii: E679. doi: 10.3390/v10120679.


Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus.

Cui Q, Cheng H, Xiong R, Zhang G, Du R, Anantpadma M, Davey RA, Rong L.

Viruses. 2018 Nov 30;10(12). pii: E678. doi: 10.3390/v10120678.


Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics.

Schafer A, Cheng H, Xiong R, Soloveva V, Retterer C, Mo F, Bavari S, Thatcher G, Rong L.

Antiviral Res. 2018 Sep;157:47-56. doi: 10.1016/j.antiviral.2018.07.003. Epub 2018 Jul 4.


A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase.

Li P, Cui Q, Wang L, Zhao X, Zhang Y, Manicassamy B, Yang Y, Rong L, Du R.

Viruses. 2018 Jun 13;10(6). pii: E325. doi: 10.3390/v10060325.


Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor.

Cui Q, Du R, Anantpadma M, Schafer A, Hou L, Tian J, Davey RA, Cheng H, Rong L.

Viruses. 2018 Mar 27;10(4). pii: E152. doi: 10.3390/v10040152.


Development of Potential Small Molecule Therapeutics for Treatment of Ebola Virus Disease.

Schafer A, Cheng H, Lee C, Du R, Han J, Perez J, Peet N, Manicassamy B, Rong L.

Curr Med Chem. 2018;25(38):5177-5190. doi: 10.2174/0929867324666171010141416. Review.


Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance.

Han J, Perez J, Schafer A, Cheng H, Peet N, Rong L, Manicassamy B.

Curr Med Chem. 2018;25(38):5115-5127. doi: 10.2174/0929867324666170920165926. Review.


Correction to Potent Inhibitor of Drug-Resistant HIV-1 Strains Identified from the Medicinal Plant Justicia gendarussa.

Zhang HJ, Rumschlag-Booms E, Guan YF, Wang DY, Liu KL, Li WF, Nguyen VH, Cuong NM, Soejarto DD, Fong HHS, Rong L.

J Nat Prod. 2017 Aug 25;80(8):2390. doi: 10.1021/acs.jnatprod.7b00562. Epub 2017 Jul 20. No abstract available.


Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.

Cheng H, Schafer A, Soloveva V, Gharaibeh D, Kenny T, Retterer C, Zamani R, Bavari S, Peet NP, Rong L.

Antiviral Res. 2017 Sep;145:24-32. doi: 10.1016/j.antiviral.2017.06.015. Epub 2017 Jun 20.


Potent Inhibitor of Drug-Resistant HIV-1 Strains Identified from the Medicinal Plant Justicia gendarussa.

Zhang HJ, Rumschlag-Booms E, Guan YF, Wang DY, Liu KL, Li WF, Nguyen VH, Cuong NM, Soejarto DD, Fong HHS, Rong L.

J Nat Prod. 2017 Jun 23;80(6):1798-1807. doi: 10.1021/acs.jnatprod.7b00004. Epub 2017 Jun 14. Erratum in: J Nat Prod. 2017 Aug 25;80(8):2390.


Molecular Mechanism Underlying the Action of Influenza A Virus Fusion Inhibitor MBX2546.

Basu A, Komazin-Meredith G, McCarthy C, Antanasijevic A, Cardinale SC, Mishra RK, Barnard DL, Caffrey M, Rong L, Bowlin TL.

ACS Infect Dis. 2017 May 12;3(5):330-335. doi: 10.1021/acsinfecdis.6b00194. Epub 2017 Apr 3.


Anti-HIV diphyllin glycosides from Justicia gendarussa.

Zhang HJ, Rumschlag-Booms E, Guan YF, Liu KL, Wang DY, Li WF, Nguyen VH, Cuong NM, Soejarto DD, Fong HHS, Rong L.

Phytochemistry. 2017 Apr;136:94-100. doi: 10.1016/j.phytochem.2017.01.005. Epub 2017 Jan 19.


Stabilization and Improvement of a Promising Influenza Antiviral: Making a PAIN PAINless.

Antanasijevic A, Hafeman NJ, Tundup S, Kingsley C, Mishra RK, Rong L, Manicassamy B, Wardrop D, Caffrey M.

ACS Infect Dis. 2016 Sep 9;2(9):608-615. Epub 2016 Aug 1.


Cell-Based High-Throughput Screening Assay Identifies 2',2'-Difluoro-2'-deoxycytidine Gemcitabine as a Potential Antipoliovirus Agent.

Zhang Z, Yang E, Hu C, Cheng H, Chen CY, Huang D, Wang R, Zhao Y, Rong L, Vignuzzi M, Shen H, Shen L, Chen ZW.

ACS Infect Dis. 2017 Jan 13;3(1):45-53. doi: 10.1021/acsinfecdis.6b00116. Epub 2016 Nov 11.


Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice.

Shen H, Wang F, Zeng G, Shen L, Cheng H, Huang D, Wang R, Rong L, Chen ZW.

Sci Rep. 2016 Sep 7;6:32725. doi: 10.1038/srep32725.


Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions.

Antanasijevic A, Kingsley C, Basu A, Bowlin TL, Rong L, Caffrey M.

J Biomol NMR. 2016 Mar;64(3):255-65. doi: 10.1007/s10858-016-0025-1. Epub 2016 Feb 26.


A High-Throughput Screening Platform Targeting PDLIM5 for Pulmonary Hypertension.

Cheng H, Chen T, Tor M, Park D, Zhou Q, Huang JB, Khatib N, Rong L, Zhou G.

J Biomol Screen. 2016 Apr;21(4):333-41. doi: 10.1177/1087057115625924. Epub 2016 Jan 13.


A parallel genome-wide RNAi screening strategy to identify host proteins important for entry of Marburg virus and H5N1 influenza virus.

Cheng H, Koning K, O'Hearn A, Wang M, Rumschlag-Booms E, Varhegyi E, Rong L.

Virol J. 2015 Nov 24;12:194. doi: 10.1186/s12985-015-0420-3.


Novel Small Molecule Entry Inhibitors of Ebola Virus.

Basu A, Mills DM, Mitchell D, Ndungo E, Williams JD, Herbert AS, Dye JM, Moir DT, Chandran K, Patterson JL, Rong L, Bowlin TL.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S425-34. doi: 10.1093/infdis/jiv223. Epub 2015 Jul 22.

Supplemental Content

Loading ...
Support Center